

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.55942732 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12657219 |
| 3 | definitive hemopoiesis (GO:0060216) | 4.93734866 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 4.80556791 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.51482249 |
| 6 | response to peptidoglycan (GO:0032494) | 4.50244675 |
| 7 | poly(A)+ mRNA export from nucleus (GO:0016973) | 4.43006395 |
| 8 | cellular extravasation (GO:0045123) | 4.40413086 |
| 9 | positive regulation of granulocyte differentiation (GO:0030854) | 4.20475688 |
| 10 | cell wall macromolecule metabolic process (GO:0044036) | 4.09972005 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07653439 |
| 12 | cell wall macromolecule catabolic process (GO:0016998) | 3.98892425 |
| 13 | negative regulation of granulocyte differentiation (GO:0030853) | 3.89569901 |
| 14 | regulation of B cell differentiation (GO:0045577) | 3.81505424 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 3.80100980 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.79768310 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.72913052 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.68400700 |
| 19 | regulation of granulocyte differentiation (GO:0030852) | 3.41941577 |
| 20 | neutrophil mediated immunity (GO:0002446) | 3.35607021 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32839488 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.32839488 |
| 23 | microglial cell activation (GO:0001774) | 3.30188676 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 3.29716966 |
| 25 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.29192834 |
| 26 | interkinetic nuclear migration (GO:0022027) | 3.24777141 |
| 27 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23865327 |
| 28 | piRNA metabolic process (GO:0034587) | 3.21606675 |
| 29 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17689026 |
| 30 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17620116 |
| 31 | negative regulation of interleukin-8 production (GO:0032717) | 3.16617052 |
| 32 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08736465 |
| 33 | neutrophil activation (GO:0042119) | 3.08653605 |
| 34 | regulation of female gonad development (GO:2000194) | 3.08325823 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.08271290 |
| 36 | regulation of leukocyte degranulation (GO:0043300) | 3.07341833 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.05437648 |
| 38 | regulation of mast cell activation (GO:0033003) | 3.02356199 |
| 39 | cellular response to exogenous dsRNA (GO:0071360) | 3.01807611 |
| 40 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.00051266 |
| 41 | mature B cell differentiation involved in immune response (GO:0002313) | 2.99878563 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99369032 |
| 43 | regulation of hypersensitivity (GO:0002883) | 2.90509204 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 2.89291581 |
| 45 | negative regulation of growth of symbiont in host (GO:0044130) | 2.88879407 |
| 46 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.88879407 |
| 47 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.88879407 |
| 48 | regulation of growth of symbiont in host (GO:0044126) | 2.88879407 |
| 49 | mannose metabolic process (GO:0006013) | 2.87160398 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 2.86835940 |
| 51 | leukocyte degranulation (GO:0043299) | 2.86173715 |
| 52 | positive thymic T cell selection (GO:0045059) | 2.84137167 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83601273 |
| 54 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.82788509 |
| 55 | megakaryocyte development (GO:0035855) | 2.82515937 |
| 56 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81159202 |
| 57 | positive regulation of mast cell degranulation (GO:0043306) | 2.81159202 |
| 58 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.80978351 |
| 59 | response to protozoan (GO:0001562) | 2.78204259 |
| 60 | regulation of erythrocyte differentiation (GO:0045646) | 2.78168634 |
| 61 | positive regulation of interleukin-17 production (GO:0032740) | 2.75960425 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 2.73245552 |
| 63 | granulocyte activation (GO:0036230) | 2.71814602 |
| 64 | detection of other organism (GO:0098543) | 2.70336138 |
| 65 | mast cell activation (GO:0045576) | 2.69605020 |
| 66 | regulation of interleukin-17 production (GO:0032660) | 2.68808589 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.67644115 |
| 68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.65887947 |
| 69 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65733747 |
| 70 | modulation by symbiont of host defense response (GO:0052031) | 2.65733747 |
| 71 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65733747 |
| 72 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65733747 |
| 73 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65733747 |
| 74 | modulation by symbiont of host immune response (GO:0052553) | 2.65733747 |
| 75 | germinal center formation (GO:0002467) | 2.65480371 |
| 76 | histone H3-K9 modification (GO:0061647) | 2.64508727 |
| 77 | activated T cell proliferation (GO:0050798) | 2.64420840 |
| 78 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.64101031 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 2.63770285 |
| 80 | negative regulation of interleukin-6 production (GO:0032715) | 2.63279582 |
| 81 | defense response to protozoan (GO:0042832) | 2.63098326 |
| 82 | myeloid leukocyte mediated immunity (GO:0002444) | 2.62873497 |
| 83 | necroptotic process (GO:0070266) | 2.62460339 |
| 84 | detection of bacterium (GO:0016045) | 2.61617667 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.60712332 |
| 86 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59164556 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.59164556 |
| 88 | histone H3-K9 methylation (GO:0051567) | 2.58608482 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 2.58040464 |
| 90 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.56905490 |
| 91 | mature B cell differentiation (GO:0002335) | 2.55478513 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.55278047 |
| 93 | regulation of platelet aggregation (GO:0090330) | 2.54612990 |
| 94 | macrophage activation (GO:0042116) | 2.53151537 |
| 95 | regulation of B cell apoptotic process (GO:0002902) | 2.51916088 |
| 96 | negative regulation of interleukin-17 production (GO:0032700) | 2.51568302 |
| 97 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50872268 |
| 98 | B cell homeostasis (GO:0001782) | 2.50160856 |
| 99 | regulation of germinal center formation (GO:0002634) | 2.49467294 |
| 100 | positive regulation of natural killer cell activation (GO:0032816) | 2.49240627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.37351941 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.87572301 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35413032 |
| 4 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.26183290 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.20955480 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.16413490 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.05081223 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00428668 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79493086 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74573832 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.71231127 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65037565 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53228704 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48415546 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.42217885 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.39232634 |
| 17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.37434677 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34647788 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.34188394 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.22785593 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.15719528 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.09864801 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.08833280 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.07616095 |
| 25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03996932 |
| 26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98570262 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89671665 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88273533 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87837253 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87008369 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83368273 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78564302 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.75573201 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63669125 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.63643878 |
| 36 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63216524 |
| 37 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.59123054 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53403841 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52576387 |
| 40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51672137 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50017155 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49594858 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.46790533 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45969720 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.40924630 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39178724 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37417207 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37229956 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32623233 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.28833762 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27959139 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25624525 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25414639 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22016180 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.21964612 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20561706 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19904685 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19684274 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19302806 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17991254 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17696242 |
| 62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15942471 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13032811 |
| 64 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.12435002 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08701525 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08618939 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08470911 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.06740253 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06130901 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05737133 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04578759 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01269923 |
| 73 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00259533 |
| 74 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98970050 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97933815 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96537126 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94518620 |
| 78 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94470467 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.94144088 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93871589 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93871589 |
| 82 | MAF_26560356_Chip-Seq_TH2_Human | 0.93632184 |
| 83 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93041952 |
| 84 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.92704925 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92644087 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91009847 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90846032 |
| 88 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90211052 |
| 89 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86458045 |
| 90 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85999136 |
| 91 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85519838 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83831396 |
| 93 | EWS_26573619_Chip-Seq_HEK293_Human | 0.83674957 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83586680 |
| 95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81550812 |
| 96 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79507069 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79317191 |
| 98 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79186909 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78702261 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78697462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.45582045 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.18219964 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.86709754 |
| 4 | MP0005397_hematopoietic_system_phenotyp | 2.76558407 |
| 5 | MP0001545_abnormal_hematopoietic_system | 2.76558407 |
| 6 | MP0005464_abnormal_platelet_physiology | 2.65181824 |
| 7 | MP0003303_peritoneal_inflammation | 2.53091478 |
| 8 | MP0009278_abnormal_bone_marrow | 2.50106298 |
| 9 | MP0003436_decreased_susceptibility_to | 2.39220728 |
| 10 | MP0002009_preneoplasia | 2.38965096 |
| 11 | MP0003724_increased_susceptibility_to | 2.35026098 |
| 12 | MP0002419_abnormal_innate_immunity | 2.32154614 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.25476954 |
| 14 | MP0001800_abnormal_humoral_immune | 2.23561006 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.16260558 |
| 16 | MP0002723_abnormal_immune_serum | 1.98294644 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.96900314 |
| 18 | MP0005025_abnormal_response_to | 1.95621476 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.94372652 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.94354944 |
| 21 | MP0001819_abnormal_immune_cell | 1.91336179 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.88556421 |
| 23 | MP0002398_abnormal_bone_marrow | 1.82666994 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.82651304 |
| 25 | MP0006082_CNS_inflammation | 1.80011239 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.79012203 |
| 27 | MP0009785_altered_susceptibility_to | 1.77821584 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.68638948 |
| 29 | MP0003828_pulmonary_edema | 1.68353479 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.67994154 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.67528097 |
| 32 | MP0000716_abnormal_immune_system | 1.65717581 |
| 33 | MP0003787_abnormal_imprinting | 1.64698192 |
| 34 | MP0008057_abnormal_DNA_replication | 1.58569637 |
| 35 | MP0000685_abnormal_immune_system | 1.58481227 |
| 36 | MP0002722_abnormal_immune_system | 1.55408995 |
| 37 | MP0005671_abnormal_response_to | 1.50474103 |
| 38 | MP0005387_immune_system_phenotype | 1.48406154 |
| 39 | MP0001790_abnormal_immune_system | 1.48406154 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.47917354 |
| 41 | MP0002405_respiratory_system_inflammati | 1.45615028 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.42924687 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.40236867 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.39023321 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.36953055 |
| 46 | MP0002429_abnormal_blood_cell | 1.35478875 |
| 47 | MP0004130_abnormal_muscle_cell | 1.33789136 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.33262831 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.32966237 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.28410101 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.22711862 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.21657498 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.20428681 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.19782358 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.19077813 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.19048548 |
| 57 | MP0005410_abnormal_fertilization | 1.15226762 |
| 58 | MP0008469_abnormal_protein_level | 1.15006045 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.14597257 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.14533455 |
| 61 | MP0002971_abnormal_brown_adipose | 1.14049497 |
| 62 | MP0002132_abnormal_respiratory_system | 1.13580447 |
| 63 | MP0004484_altered_response_of | 1.11405246 |
| 64 | MP0002006_tumorigenesis | 1.11170016 |
| 65 | MP0009764_decreased_sensitivity_to | 1.10552121 |
| 66 | MP0001851_eye_inflammation | 1.10193039 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.07415094 |
| 68 | MP0003195_calcinosis | 1.06327961 |
| 69 | MP0005535_abnormal_body_temperature | 1.06116215 |
| 70 | MP0001853_heart_inflammation | 1.04363702 |
| 71 | MP0003646_muscle_fatigue | 1.04103863 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.00573479 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.98021125 |
| 74 | MP0001764_abnormal_homeostasis | 0.94165882 |
| 75 | MP0009115_abnormal_fat_cell | 0.91243996 |
| 76 | MP0009379_abnormal_foot_pigmentation | 0.87683448 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.87619244 |
| 78 | MP0005334_abnormal_fat_pad | 0.86667026 |
| 79 | MP0001765_abnormal_ion_homeostasis | 0.85878480 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.83848833 |
| 81 | MP0005310_abnormal_salivary_gland | 0.82533444 |
| 82 | MP0003252_abnormal_bile_duct | 0.78642803 |
| 83 | MP0003045_fibrosis | 0.78595962 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.76697630 |
| 85 | MP0004947_skin_inflammation | 0.76383456 |
| 86 | MP0001873_stomach_inflammation | 0.74874268 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.73355676 |
| 88 | MP0005670_abnormal_white_adipose | 0.72984967 |
| 89 | MP0001929_abnormal_gametogenesis | 0.71440342 |
| 90 | MP0002928_abnormal_bile_duct | 0.71250244 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.71006780 |
| 92 | MP0003075_altered_response_to | 0.70941911 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 0.69236701 |
| 94 | MP0003959_abnormal_lean_body | 0.67307770 |
| 95 | MP0003690_abnormal_glial_cell | 0.66124705 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.65963514 |
| 97 | MP0003866_abnormal_defecation | 0.65657761 |
| 98 | MP0003786_premature_aging | 0.65171226 |
| 99 | MP0003698_abnormal_male_reproductive | 0.64870054 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.63940409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute lymphatic leukemia (HP:0006721) | 4.92620969 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83629539 |
| 3 | Myositis (HP:0100614) | 3.96460485 |
| 4 | Stomatitis (HP:0010280) | 3.95571226 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.84019433 |
| 6 | Acute myeloid leukemia (HP:0004808) | 3.77362193 |
| 7 | Prolonged bleeding time (HP:0003010) | 3.61473229 |
| 8 | Recurrent cutaneous fungal infections (HP:0011370) | 3.59692378 |
| 9 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.59692378 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54731679 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.49967228 |
| 12 | Abnormality of B cell number (HP:0010975) | 3.45118078 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.37767363 |
| 14 | B lymphocytopenia (HP:0010976) | 3.27013025 |
| 15 | Thrombocytosis (HP:0001894) | 3.22137563 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 3.14077485 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06999872 |
| 18 | Abnormality of macular pigmentation (HP:0008002) | 3.03282752 |
| 19 | Recurrent skin infections (HP:0001581) | 2.94132179 |
| 20 | Thoracic kyphosis (HP:0002942) | 2.92299228 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.83214601 |
| 22 | Epistaxis (HP:0000421) | 2.82998682 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 2.79151781 |
| 24 | Abnormality of the prostate (HP:0008775) | 2.78580193 |
| 25 | Encephalitis (HP:0002383) | 2.78027941 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 2.75689154 |
| 27 | Meningitis (HP:0001287) | 2.71606825 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.71574492 |
| 29 | Chest pain (HP:0100749) | 2.70825440 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.69573865 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.68946427 |
| 32 | Metaphyseal dysplasia (HP:0100255) | 2.68178707 |
| 33 | Recurrent viral infections (HP:0004429) | 2.63838357 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63125387 |
| 35 | Obstructive lung disease (HP:0006536) | 2.63125387 |
| 36 | Orchitis (HP:0100796) | 2.63101901 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 2.61591336 |
| 38 | Gingival bleeding (HP:0000225) | 2.61193099 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 2.60296799 |
| 40 | Abnormality of the lumbar spine (HP:0100712) | 2.58069691 |
| 41 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.56724573 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.53803599 |
| 43 | Episodic fever (HP:0001954) | 2.52772303 |
| 44 | Granulocytopenia (HP:0001913) | 2.52333368 |
| 45 | Optic neuritis (HP:0100653) | 2.52318782 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.52318782 |
| 47 | Papilledema (HP:0001085) | 2.50081758 |
| 48 | Abnormality of T cells (HP:0002843) | 2.45022640 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44611797 |
| 50 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.42277082 |
| 51 | Vasculitis (HP:0002633) | 2.36840638 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.35679050 |
| 53 | Hemoptysis (HP:0002105) | 2.34767715 |
| 54 | Pulmonary embolism (HP:0002204) | 2.31056536 |
| 55 | Petechiae (HP:0000967) | 2.29949116 |
| 56 | Arterial thrombosis (HP:0004420) | 2.29233572 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.27637941 |
| 58 | Amyloidosis (HP:0011034) | 2.23526214 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.22103489 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.22103489 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.22103489 |
| 62 | Leukocytosis (HP:0001974) | 2.21903898 |
| 63 | Severe visual impairment (HP:0001141) | 2.20394508 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.18546654 |
| 65 | Spondylolisthesis (HP:0003302) | 2.18064854 |
| 66 | Autoimmune hemolytic anemia (HP:0001890) | 2.17300088 |
| 67 | Thickened calvaria (HP:0002684) | 2.17164404 |
| 68 | Pustule (HP:0200039) | 2.15381160 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.11788680 |
| 70 | Neurodegeneration (HP:0002180) | 2.08857944 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.08680404 |
| 72 | T lymphocytopenia (HP:0005403) | 2.06945635 |
| 73 | Central scotoma (HP:0000603) | 2.06453559 |
| 74 | Constricted visual fields (HP:0001133) | 2.04757907 |
| 75 | Colitis (HP:0002583) | 2.03974944 |
| 76 | Abnormality of the thoracic spine (HP:0100711) | 2.03322209 |
| 77 | Abnormality of T cell number (HP:0011839) | 1.99114693 |
| 78 | Decreased central vision (HP:0007663) | 1.98267105 |
| 79 | Eczematoid dermatitis (HP:0000976) | 1.97433118 |
| 80 | Increased IgE level (HP:0003212) | 1.96807124 |
| 81 | Chronic diarrhea (HP:0002028) | 1.95629731 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94934798 |
| 83 | Pulmonary infiltrates (HP:0002113) | 1.94287490 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 1.93936985 |
| 85 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93910924 |
| 86 | Severe combined immunodeficiency (HP:0004430) | 1.92555694 |
| 87 | Cheilitis (HP:0100825) | 1.90713583 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89763869 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89763869 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89763869 |
| 91 | Fatigue (HP:0012378) | 1.86722733 |
| 92 | Dyschromatopsia (HP:0007641) | 1.82560404 |
| 93 | Mucopolysacchariduria (HP:0008155) | 1.82487116 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82487116 |
| 95 | Abnormality of the columella (HP:0009929) | 1.78362375 |
| 96 | Urticaria (HP:0001025) | 1.78080005 |
| 97 | Autoimmune thrombocytopenia (HP:0001973) | 1.77713341 |
| 98 | Microcytic anemia (HP:0001935) | 1.77580783 |
| 99 | Acute hepatic failure (HP:0006554) | 1.77239450 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 1.77140179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.41129389 |
| 2 | RIPK4 | 3.40484355 |
| 3 | MAP3K13 | 3.23570452 |
| 4 | TAOK3 | 3.04187959 |
| 5 | FRK | 2.96735521 |
| 6 | TEC | 2.69470353 |
| 7 | FES | 2.56991676 |
| 8 | MAP3K14 | 2.37724475 |
| 9 | MAP4K1 | 2.32560283 |
| 10 | FLT3 | 2.24252304 |
| 11 | MAP2K3 | 2.24146460 |
| 12 | TXK | 2.18915005 |
| 13 | CSF1R | 2.04137756 |
| 14 | SYK | 1.99839750 |
| 15 | CDK6 | 1.90731867 |
| 16 | BTK | 1.89135213 |
| 17 | ZAP70 | 1.76136184 |
| 18 | MAP3K6 | 1.71583955 |
| 19 | ITK | 1.70496070 |
| 20 | TNK2 | 1.69680344 |
| 21 | TBK1 | 1.56264005 |
| 22 | TRPM7 | 1.56012540 |
| 23 | BLK | 1.49744596 |
| 24 | PIK3CG | 1.42717023 |
| 25 | GRK6 | 1.40519144 |
| 26 | CDK19 | 1.36261846 |
| 27 | ERN1 | 1.34710603 |
| 28 | DAPK2 | 1.33299676 |
| 29 | HCK | 1.30199720 |
| 30 | IKBKB | 1.28232625 |
| 31 | JAK3 | 1.27894940 |
| 32 | TYK2 | 1.27484357 |
| 33 | MATK | 1.22707479 |
| 34 | HIPK2 | 1.22276548 |
| 35 | IRAK4 | 1.21934909 |
| 36 | BMPR2 | 1.21690929 |
| 37 | PRPF4B | 1.19552992 |
| 38 | LYN | 1.18586879 |
| 39 | BRD4 | 1.14710139 |
| 40 | MAP3K7 | 1.14264241 |
| 41 | NUAK1 | 1.12031163 |
| 42 | MAP2K6 | 1.11496829 |
| 43 | CDK3 | 1.03480382 |
| 44 | PDK1 | 1.01195645 |
| 45 | LCK | 1.01038295 |
| 46 | MARK3 | 0.98587564 |
| 47 | MAP4K2 | 0.95708222 |
| 48 | MAPK7 | 0.95307324 |
| 49 | IKBKE | 0.94375765 |
| 50 | ACVR1B | 0.90214995 |
| 51 | PRKCQ | 0.89936632 |
| 52 | RPS6KA4 | 0.85764373 |
| 53 | YES1 | 0.85326109 |
| 54 | MAPK12 | 0.84326201 |
| 55 | ADRBK2 | 0.82480505 |
| 56 | RPS6KA6 | 0.82047919 |
| 57 | JAK2 | 0.80316807 |
| 58 | CSK | 0.80053884 |
| 59 | RPS6KL1 | 0.79715951 |
| 60 | RPS6KC1 | 0.79715951 |
| 61 | MAP2K2 | 0.79293568 |
| 62 | PDPK1 | 0.77252560 |
| 63 | RPS6KB2 | 0.72405287 |
| 64 | CDK4 | 0.64772600 |
| 65 | JAK1 | 0.64678325 |
| 66 | PRKAA2 | 0.64096046 |
| 67 | IRAK1 | 0.61023272 |
| 68 | PTK2B | 0.60416078 |
| 69 | STK11 | 0.59570478 |
| 70 | INSRR | 0.58698742 |
| 71 | CAMK1G | 0.57848241 |
| 72 | PASK | 0.57247099 |
| 73 | PRKG2 | 0.56636633 |
| 74 | MAPK11 | 0.49614178 |
| 75 | PIM1 | 0.47384405 |
| 76 | TAF1 | 0.47249489 |
| 77 | NEK9 | 0.46571296 |
| 78 | MAP2K4 | 0.46047697 |
| 79 | EEF2K | 0.45203108 |
| 80 | MAPK3 | 0.44624598 |
| 81 | CDK12 | 0.44294760 |
| 82 | PLK4 | 0.42993938 |
| 83 | WNK1 | 0.41588687 |
| 84 | ABL1 | 0.40560020 |
| 85 | GRK7 | 0.38629469 |
| 86 | MAPK4 | 0.38356701 |
| 87 | MAP3K5 | 0.37752331 |
| 88 | SGK1 | 0.35948341 |
| 89 | RET | 0.33839228 |
| 90 | MKNK1 | 0.33461729 |
| 91 | MAP3K1 | 0.32155055 |
| 92 | CAMK1 | 0.32136665 |
| 93 | MAPK13 | 0.31472758 |
| 94 | ADRBK1 | 0.30435036 |
| 95 | RPS6KB1 | 0.30246619 |
| 96 | IGF1R | 0.28914949 |
| 97 | MAPK10 | 0.27151449 |
| 98 | PINK1 | 0.27066348 |
| 99 | CAMKK2 | 0.26677345 |
| 100 | MAPK1 | 0.23256965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.95888605 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.74713379 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57780325 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.51112880 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.45964234 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26560345 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22945326 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15113321 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.12337990 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10383533 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01109094 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96342818 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.89767602 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73561532 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72915048 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67399184 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.66164963 |
| 18 | Platelet activation_Homo sapiens_hsa04611 | 1.63366036 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.58628243 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54357513 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47481518 |
| 22 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.45942442 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45594233 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45189521 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41955546 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.32205318 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.31173001 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28608471 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27239641 |
| 30 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.24581213 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20646088 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20166630 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20139067 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19094669 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16425194 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.12809796 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12502278 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09363976 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.00739237 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 0.98862820 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98010534 |
| 42 | Malaria_Homo sapiens_hsa05144 | 0.96553329 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93406630 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92749712 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91378019 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.89860973 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89840136 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88498542 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.87486522 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86420285 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86224862 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85786173 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.85476076 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84172133 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.83800469 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79133920 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76996679 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76690527 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75465967 |
| 60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74853992 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.74192123 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73766245 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72795437 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72179901 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72019818 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70781098 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.69122462 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68710027 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66436454 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64964445 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63894006 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62239537 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60222435 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59089345 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57976388 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57528682 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56552414 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.53688643 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53682238 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52991517 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52835491 |
| 82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52079991 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52032648 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51721557 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50954283 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49219196 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48546992 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.48395679 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46771281 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45112444 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44993398 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44354555 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44328495 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43145515 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41919429 |
| 96 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40948679 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40205391 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38650549 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37640144 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37275468 |

